(Q56944980)

English

Prior aspirin use predicts worse outcomes in patients with non–ST-elevation acute coronary syndromes11This study was sponsored by COR Therapeutics Inc., South San Francisco, California; and Schering-Plough Research Institute, Kenilworth, New Jersey

article

In more languages

Statements

scholarly article

0 references

Prior aspirin use predicts worse outcomes in patients with non–ST-elevation acute coronary syndromes11This study was sponsored by COR Therapeutics Inc., South San Francisco, California; and Schering-Plough Research Institute, Kenilworth, New Jersey (English)

0 references

0 references

1 reference

based on heuristic

inferred from title

object named as

Eric J Topol

14

0 references

Paul W. Armstrong

object named as

Paul W Armstrong

20

0 references

Robert A Harrington

2

object named as

Robert A Harrington

0 references

13

object named as

Robert M Califf

0 references

Maarten L Simoons

7

object named as

Maarten L Simoons

0 references

Witold Rużyłło

16

object named as

Witold Ruzyllo

0 references

John H. Alexander

1

object named as

John H Alexander

0 references

Judith S Hochman

9

object named as

Judith S Hochman

0 references

10

object named as

Robert G Wilcox

0 references

4

object named as

Lisa G Berdan

0 references

6

object named as

Jaap W Deckers

0 references

A Michael Lincoff

5

object named as

A.Michael Lincoff

0 references

author name string

Robert H Tuttle

3

0 references

Alan Guerci

8

0 references

Michael M Kitt

11

0 references

Paul R Eisenberg

12

0 references

Karl Karsh

15

0 references

Janine Stepinska

17

0 references

Peter Widimsky

18

0 references

Jean B Boland

19

0 references

language of work or name

0 references

publication date

April 1999

0 references

American Journal of Cardiology

0 references

83

0 references

8

0 references

1147-1151

0 references

Are we mortgaging the medical profession?

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900049-1

7 January 2021

Antiplatelet agents in the prevention and therapy of thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900049-1

7 January 2021

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900049-1

7 January 2021

Diagnosing and managing unstable angina. Agency for Health Care Policy and Research

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900049-1

7 January 2021

Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900049-1

7 January 2021

Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900049-1

7 January 2021

Aspirin as a therapeutic agent in cardiovascular disease: a statement for healthcare professionals from the American Heart Association

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900049-1

7 January 2021

Final report on the aspirin component of the ongoing Physicians' Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900049-1

7 January 2021

Two-year follow-up of aspirin responder and aspirin non responder. A pilot-study including 180 post-stroke patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900049-1

7 January 2021

Development of aspirin resistance in persons with previous ischemic stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900049-1

7 January 2021

A Randomized Trial of Aspirin and Sulfinpyrazone in Threatened Stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900049-1

7 January 2021

Sex differences in bleeding time and blood loss in normal subjects following aspirin ingestion

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900049-1

7 January 2021

Sex difference in antithrombotic effect of aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900049-1

7 January 2021

Erythrocyte promotion of platelet reactivity decreases the effectiveness of aspirin as an antithrombotic therapeutic modality: the effect of low-dose aspirin is less than optimal in patients with vascular disease due to prothrombotic effects of eryt

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900049-1

7 January 2021

Prothrombotic effects of erythrocytes on platelet reactivity. Reduction by aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900049-1

7 January 2021

Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900049-1

7 January 2021

Stroke in patients with acute coronary syndromes: incidence and outcomes in the platelet glycoprotein IIb/IIIa in unstable angina. Receptor suppression using integrilin therapy (PURSUIT) trial. The PURSUIT Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900049-1

7 January 2021

Quality of care for Medicare patients with acute myocardial infarction. A four-state pilot study from the Cooperative Cardiovascular Project

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900049-1

7 January 2021

Potential impact of evidence-based medicine in acute coronary syndromes: insights from GUSTO-IIb. Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900049-1

7 January 2021

Variations in Patient Management and Outcomes for Acute Myocardial Infarction in the United States and Other Countries

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900049-1

7 January 2021

Effects of prior aspirin and anti-ischemic therapy on outcome of patients with unstable angina. TIMI 7 Investigators. Thrombin Inhibition in Myocardial Ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900049-1

7 January 2021

Prospective Comparison of Patient Characteristics and Outcome of Non-prior Aspirin Users versus Aspirin Users with Unstable Angina or Non-Q-Wave Myocardial Infarction Treated with Combination Antithrombotic Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900049-1

7 January 2021

Previous aspirin use may attenuate the severity of the manifestation of acute ischemic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900049-1

7 January 2021

Does aspirin consumption affect the presentation or severity of acute myocardial infarction?

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900049-1

7 January 2021

Clinical characteristics of nonfatal myocardial infarction among individuals on prophylactic low-dose aspirin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900049-1

7 January 2021

Unstable angina or non-Q wave infarction despite long-term aspirin: response to thrombolytic therapy with implications on mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900049-1

7 January 2021

Clinical and angiographic characteristics and outcome of patients with rest-unstable angina occurring during regular aspirin use.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900049-1

7 January 2021

Identifiers

10.1016/S0002-9149(99)00049-1

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q56944980&oldid=1982955000"